2016 New Frontiers in the Italian Cancer Diagnostics Market is VPGMarketResearchs new study of the major business opportunities emerging in the Italian cancer diagnostics market during the nextfive years. The report examines trends in the Italian cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Italy Market Overview
- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Immunohistochemical Stains, and others.
- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major cancer diagnostic product
suppliers by individual test.
- Five-year test volume and sales forecasts
for major tumor markers by market segment, including:
- Commercial/Private Laboratories
- Analysis of major molecular diagnostic and immunodiagnostic analyzers
used for cancer testing, including their operating characteristics,
features and selling prices.
- Assessment of latest molecular diagnostic methods,
biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,
chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies
and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.
- Extensive listings of companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.
- Strategic assessments ofmajor suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.
- The companies analyzed in the report include
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- Correlogic Systems/Vermillion
- Decode Genetics
- Eiken Chemical
Contains 570 pages and 83 tables
SIMILAR MARKET STUDIES
This report is a crucial resource for industry executives and anyone looking to access key information about "Carrefour S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
May 2014 | $125 | View Details >>
Stem Cells Cryopreservation Equipment (SCCE) is medical equipment used in the freezing and storage for stem cells. Cryopreservation is the use of low temperatures to preserve structurally intact living stem cells. Scope of the Report: This report focuses on the Stem Cells Cryopreservation Equipments in Global market, especially in North America, ...
December 2016 | $3480 | View Details >>
This DataPack contains tables from VPGMarketResearch.com new report, 2016 Japan Hospital Hemostasis Diagnostics Market. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
2016 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Strategies (DataPack)
This DataPack contains tables from VPGMarketResearch.com new report, 2016 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Strategies. For pricing information on DataPack sections or individual tables, please contact Customer Service.
February 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research